19
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Microvascular Remodeling: A Complex Continuum Spanning Angiogenesis to Arteriogenesis

&
Pages 99-111 | Published online: 10 Jul 2009

REFERENCES

  • Achard J, Fournier A, Mazouz H, Caride VJ, Penar PL, Fernandez LA. (2001). Protection against is-chemia: A physiological function of the renin-angiotensin system. Biochem Pharmacol 62:261–271.
  • Adair TH, Guyton AC, Montani JP, Lindsay HL, Stanek KA. (1987). Whole body structural vascular adaptation to prolonged hypoxia in chick embryos. Am J Physiol 252:H1228–H1234.
  • Mon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. (1995). VEGF acts as a survival factor for newly-formed retinal vessels: Implications for ROP. Nat Med 1:1024–1028.
  • Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. (1998). Monocyte activation in angio-genesis and collateral growth in the rabbit hincllirnb. J Clin Invest 101:40–50.
  • Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM. (1998). Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83:233–240.
  • Asahara T, Takahashi T, Masuda H, Kalda C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. (1999). VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial pro-genitor cells. E114130 J18:3964–3972.
  • Ashoori F, Suzuki S, Zhou J, Nishigaki I, Takahashi R. (1996). Possible contributions of mastocytosis, apoptosis, and hydrolysis in pathophysiology of ran- domized skin flaps in humans and guinea pigs. Plast Reconstr Surg 98:491–501.
  • Bautz F, Rafii S, Kanz L, Mohle R. (2000). Expres-sion and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic pro-genitor cells: Possible role in the hematopoietic mi-croenvironrnent. Exp Hematol 28:700–706.
  • Beck H, Acker T, Wiessner C, Allegrini PR, Plate KB. (2000). Expression of angiopoietin-1, angio-poietin-2, and tie receptors after middle cerebral ar-tery occlusion in the rat. Am J Pathol 157:1473–1483.
  • Benjamin LE, Hemo I, Keshet E. (1998). A plastic-ity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125(suppl):1591–1598.
  • Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. (1999). Selective ablation of immature blood vessels in established human tumor follows vascular endo-thelial growth factor withdraw. J Clin Invest 103: 159–165.
  • Bingle L, Brown NJ, Lewis CE. (2002). The role of tumour-associated macrophages in tumour progres-sion: Implications for new anticancer therapies. J Pathol 196:254–265.
  • Bloor CM, Liebow AA. (1965). Coronary collateral circulation. Am J Cardiol 16:238–252.
  • Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. (1998). Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E- de-pendent upregulation of FCE receptor I expression. J Exp Med 188:1135–1145.
  • Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. (1994). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157–1164.
  • Buschrnann I, Schaper W. (2000). The pathophysi-ology of the collateral circulation (arteriogenesis). J Pathol 190:338–342.
  • Cai W, Vosschulte R, Afsah-Hedjri A, Koltai S, Koc-sis E, Scholz D, Kostin S, Schaper W, Schaper J. (2000). Altered balance between extracellular pro-teolysis and antiproteolysis is associated with adap-tive coronary arteriogenesis. J Mol Cell Cardiol 32: 997–1011.
  • Campbell AT, Zhao Y, Sandhu R, Stewart DJ. (2001). Cell-based gene transfer of vascular endo-thelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104: 2242–2248.
  • Carmeliet P, Luttun A. (2001). The emerging role of bone marrow-derived stem cells in (therapeutic) an-giogenesis. Thromb Haemost 86:289–297.
  • Carmeliet P, Storkebaurn E. (2002). Vascular and neuronal effects of VEGF in the nervous system: Implications for neurological disorders. Semin Cell Dev Biol 13:39–53.
  • Chan WY, Cheng RS, Yew DT. (2000). Postnatal changes of vascular endothelial growth factor (VEGF) expression in the retina of normal and hy-pertensive rats. Life Sci 66:1615–1625.
  • Chang C, Werb Z. (2001). The many faces of me-talloproteases: Cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11:S37–S43.
  • Chan-Ling T, Gock B, Stone J. (1995). The effect of oxygen on vasoformative cell division: Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36: 1201–1214.
  • Charan NB, Baile EM, Pare PD. (1997). Bronchial vascular congestion and angiogenesis. Eur Respir J 10:1173–1180.
  • Chawla PS, Keelan M H, Kipshidze N. (1999). An-giogenesis for the treatment of vascular diseases. Int Angiol 18:185–192.
  • Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O'Reilly M, Folkman J. (1998). Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Nat Acad Sci USA 95:5579–5583.
  • Clark ER, Clark EL. (1940). Microscopic observa-tions on the extra-endothelial cells of living mam-malian blood vessels. Am J Anat 66:1–49.
  • Coyle P, Heistad DD. (1991). Development of col-laterals in the cerebral circulation. Blood Vessels 28: 183–189.
  • Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, Bowen-Pope DF. (2000). Endothelial cells of hematopoietic origin make a sig-nificant contribution to adult blood vessel forma-tion. Circ Res 87:729–730.
  • Davies PF, Shi C, Depaola N, Helrnke BP, Polacek DC. (2001). Hemodynarnics and the focal origin of atherosclerosis: A spatial approach to endothelial structure, gene expression, and function. Ann N Y Acad Sci 947:7–16.
  • Deindl E, Buschrnann I, Hoeffer 1E, Podzuweit T, Boengler K, Vogel S, Van Royen N, Fernandez B, Schaper W. (2001). Role of ischemia and of hypox-ia-inducible genes in arteriogenesis after femoral ar-tery occlusion in the rabbit. Circ Res 89:779–786.
  • Demoyer JS, Skalak TC, Durieux ME. (2000). Ly-sophosphatidic acid enhances healing of acute cuta-neous wounds in the mouse. Wound Repair Regen 8:530–537.
  • Dobrian A, Wade SS, Prewitt RL. (1999). PDGF-A expression correlates with blood pressure and re-modeling in 1K1C hypertensive rat arteries. Am J Physiol 276:H2159–H2167.
  • Ferrara N, Gerber HP. (2001). The role of vascular endothelial growth factor in angiogenesis. Acta Hae-matol 106:148–156.
  • Folkman J, Magsbrun M. (1987). Angiogenic fac-tors. Science 235:442–447.
  • Folkman J. (1991). What is the evidence that tu-mors are angiogenesis-dependent? J Natl Cancer Inst 82:4–6.
  • Folkman J. (1995). Angiogenesis in cancer, vascu-lar, rheumatoid and other disease. Nat Med 1:27–31.
  • Folkman J. (2001). Angiogenesis-dependent dis-eases. Semin Oncol 28:536–542.
  • Folkman J, Browder T, Pahnblad J. (2001). Angio-genesis research: Guidelines for translation to clini-cal application. Thromb Haemost 86:23–33.
  • Fraser A, Fearon U, Reece R, Emery P, Veale DJ. (2001). Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 44:2024–2028.
  • Freedman SB, Isner JM. (2002). Therapeutic angio-genesis for coronary artery disease. Ann Intern Med 136:54–71.
  • Gardner TW, Antonetti DA, Barber AJ, Lalloue KF, Nakamura M. (2000). New insights into the patho-physiology of diabetic retinopathy: Potential cell-specific therapeutic targets. Diabetes Technol Ther 2:601–608.
  • Gargett CE, Lederman F, Heryanto B, Garnbino LS, Rogers PA. (2001). Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium: Role of intravascular neutrophils. Hum Reprod 16:1065–1075.
  • Gazit Y, Baish JW, Safabakhsh N, Leunig M, Baxter LT, Jain RK. (1997). Fractal characteristics of tu-mor vascular architecture during tumor growth and regression. Microcirculation 4:395–402.
  • Gee MS, Koch CJ, Evans SM, Jenkins WT, Pletcher CH Jr, Moore JS, Koblish HK, Lee J, Lord EM, Trinchieri G, Lee W1VI. (1999). Hypoxia-mediated apoptosis from angiogenesis inhibition underlies tu-mor control by recombinant interleukin 12. Cancer Res 59:4882–4889.
  • Gerritsen ME, Soriano R, Yang S, Ingle G, Zlot C, Toy K, Winer J, Draksharapu A, Peale F, Wu TD, Williams PM. (2002). In silico data filtering to iden-tify new angiogenesis targets from a large in vitro gene profiling data set. Physiol Genomics 10:13–20.
  • Giatromanolaki A, Sivridis E, Athanassou N, Zios E, Thorpe PE, Brekken RA, Gatter KC, Harris AL, Koukourakis IM, Koukourakis MI. (2001). The an-giogenic pathway 'vascular endothelial growth fac-tor/flk 1(KDR)-receptor' in rheumatoid arthritis and osteoarthritis. J Pathol 194:101–108.
  • Girnbrone MA, Topper JN, Nagel T, Anderson KR, Garcia-Gardena G. (2000). Endothelial dysfunc-tion, hemodynarnic forces, and atherogenesis. Ann N Y Acad Sci 902:230–239.
  • Gorge G, Schmidt T, Ito BR, Pantely GA, Schaper W. (1989). Microvascular and collateral adaptation in swine hearts following progressive coronary ar-tery stenosis. Basic Res Cardiol 84:524–535.
  • Greene AS, Cowley AW. (1998). Life and death in the microcirculation: A role for angiotensin II. Mi-crocirculation 5:101–107.
  • Greene AS, Amaral SL. (2002). Microvascular an-giogenesis and the renin-angiotensin system. Curr Hypertens Rep 4:56–62.
  • Gurunluoglu R, Lubiatowski P, Goldman GK, Car-mevale K, Siemionow M. (2002). Enhancement of muscle flap hemodynarnics by angiopoietin-1. Ann Plast Surg 48:401–409.
  • Haas TL, Milkiewicz M, Davis SJ, Zhou AL, Eggin-ton S, Brown MD, Madri JA, Hudlicka O. (2000). Matrix metalloproteinase activity is required for ac-tivity-induced angiogenesis in rat skeletal muscle. Am J Physiol 279:H1540–H1547.
  • Hackett SF, Ozaki H, Strauss RW, Wahlin K, Suni C, Maisonpierre P, Yancopoulos G, Carnpochiaro PA. (2000). Angiopoietin 2 expression in the retina: Upregulation during physiologic and pathologic neovascularization. J Cell Physiol 184:275–284.
  • Hacking WJ, VanBavel E, Spaan JA. (1996). Shear stress is not sufficient to control growth of vascular networks: A model study. Am J Physiol 270:H364–H375.
  • Hansen-Smith F, Egginton S, Zhou A, Hudlicka O. (2001). Growth of arterioles procedes that of capil-laries in stretch-induced angiogenesis in skeletal muscle. Microvasc Res 62:1–14.
  • Hautrnann MB, Madsen CS, Owens GK. (1997). A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in con-cert with two CArG elements. J Biol Chem 272: 10948–10956.
  • Hebling PM, Saulnier DM, Brandli AW. (2000). The receptor tyrosine kinase EphB4 and ephrin-B li-gands restrict angiogenic growth of embryonic veins in Xenopus laevis. Development 127(suppl):269–278.
  • Heil M, Clauss M, Suzuki K, Buschrnann IR, Willu-weit A, Fischer S, Schaper W. (2000). Vascular en-dothelial growth factor (VEGF) stimulates mono-cyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol 79: 850–857.
  • Heimann R, Hellman S. (1998). Aging, progression, and phenotype in breast cancer. J Clin Oncol 16: 2686–2692.
  • Hellstrom M, Kal M, Lindahl P, Abrarnsson A, Bet-sholtz C. (1999). Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126(suppl):3047–3055.
  • Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H, Betsholtz C. (2001). Lack of pen- cytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153: 543–553.
  • Hendrix MJ, Seftor RE, Seftor EA, Grurnan LM, Lee LM, Nickoloff BJ, Miele L, Sheriff DD, Schatteman GC. (2002). Transendothelial function of human metastatic melanoma cells: Role of the microenvi-ronrnent in cell-fate determination. Cancer Res 62: 665–668.
  • Henke C, Fiegel V, Peterson M, Wick M, Knighton D, McCarthy J, Bitterman P. (1991). Identification and partial characterization of angiogenesis bioac-tivity in the lower respiratory tract after acute lung injury. J Clin Invest 88:1386–1395.
  • Herrmann HJ, Behrn R, Huckstorf C, Norden C, Muhlig P. (1987). Hypoxia-induced regression of adaptive structural microvessel reactions caused by long-term contraction influences in spontaneously hypertensive rats (SHR). Biomed Biochim Acta. 46: 983–986.
  • Hershey JC, Baskin EP, Glass JD, Hartman HA, Gil-berto DB, Rogers IT, Cook JJ. (2001). Revascular- ization in the rabbit hindlirnb: Dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 49:618–625.
  • Hirschi KK, D'Amore PA. (1996). Pericytes in themicrovasculature. Cardiovasc Res 32:687–698.
  • Hirschi KK, Rohovsky SA, D'Arnore PA. (1998). PDGF, TGF-b, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141:805–814.
  • Hirschi KK, Skalak TC, Peirce SM, Little CD. (2002). Vascular assembly in natural and engi-neered tissues. Ann N Y Acad Sci 961:223–242.
  • Hoefer IE, Van Royen N, Buschrnann IR, Piek JJ, Schaper W. (2001). Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 49:609–617.
  • Hoefer IE, Van Royen N, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL, Voskuil M, Piek JJ, Buschmann IR, Ozaki CK. (2002). Direct evidence for tumor necrosis factor-alpha signaling in arterio-genesis. Circulation 105:1639–1641.
  • Holash J, Wiegand SJ, Yancopoulous GC. (1999). New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356–5362.
  • Holycross BJ, Blank RS, Thompson MM, Peach MJ, Owens GK. (1992). Platelet-derived growth factor- BB-induced suppression of smooth muscle cell dif-ferentiation. Circ Res 71:1525–1532.
  • Hudlicka O, Milkiewicz M, Cotter MA, Brown MD. (2002). Hypoxia and expression of VEGF-A protein in relation to capillary growth in electrically stimu-lated rat and rabbit skeletal muscles. Exp Physiol 87:373–381.
  • Hughes GC, Biswas SS, Yin B, Baldanov DV, Annex BH, Coleman RE, DeGrado TR, Landolfo CK, Landolfo KP, Lowe JE. (2002). A comparison of mechanical and laser transmyocardial revascular-ization for induction of angiogenesis and arteriogen-esis in chronically ischemic myocardium. J Am Coll Cardiol 39:1220–1228.
  • Hughson MD, He Z, Henegar J, McMurray R. (2001). Alveolar hemorrhage and renal microangi-opathy in systemic lupus erythematosus. Arch Pathol Lab Med 125:475–483.
  • Isner IM, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J, Rosenfield K, Weir L, Brogi E, Jurayj D. (1996). Arterial gene transfer for therapeutic angio-genesis in patients with peripheral artery disease. Hum Gene Ther 7:959–988.
  • Isner IM, Losordo DW. (2002). Angiogenic gene therapy: Pre-clinical studies and phase I clinical data. Kidney Int 61:110–104.
  • Isoyarna S. (1994). Hypertension and age-related changes in the heart. Implications for drug therapy. Drugs Aging 5:102–115.
  • Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W. (1997). Angiogenesis but not collateral growth is associated with ischemia after femoral ar-tery occlusion. Am J Physiol 273:H1255–H1265.
  • Jain RK, Safabakhsh N, Sckell A, Chen Y, Jiang P, Benjamin L, Yuan F, Keshet E. (1988). Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor. Proc Natl Acad Sci USA 95:10820–10825.
  • Jozsi AC, Dupont-Versteegden EE, Taylor-Jones JM, Evans WJ, Trappe TA, Campbell WW, Peterson CA. (2000). Aged human muscle demonstrates an al-tered gene expression profile consistent with an im-paired response to exercise. Mech Aging Dev 120: 45–56.
  • Kai H, Kuwahara F, Tokuda K, Shibata R, Kusaba K, Niiyama H, Tahara N, Nagata T, Irnaizurni T. (2002). Coexistence of hypercholesterolemia and hypertension impairs adventitial vascularization. Hypertension 39:455–459.
  • Kalka C, Masuda H, Takahashi T, Gordon R, Tep-per O, Gravereaux E, Pieczek A, Iwaguro H, Haya-shi SI, Isner JM, Asahara T. (2000). Vascular endo-thelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86:1198–1202.
  • Kersten JR, Pagel PS, Chilian W1VI, Warltier DC. (1999). Multifactorial basis for coronary collateral-ization: A complex adaptive response to ischemia. Cardiovasc Res 43:44–57.
  • Kocher AA, Schuster MD, Szabolcs MJ, Takurna S, Burkhoff D, Wang J, Homma S, Edwards NM, hescu S. (2001). Neovascularization of ischemic myocar-dium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodel-ing and improves cardiac function. Nat Med 7:430–436.
  • Laird AD, Christensen JG, Li G, Carver J, Smith K, Xin X, Moss KG, Louie SG, Mendel DB, Cherrington JM. (2002). SU6668 inhibits Flk-1/KDR and PDG-FRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice. FASER J 16:681–690.
  • Lange-Asschenfeldt B, Velasco P, Streit M, Hawighorst T, Pike SE, Tosato G, Detmar M. (2001). The angiogenesis inhibitor vasostatin does not impair wound healing at tumor-inhibiting doses. J Invest Dermatol 117:1036–1041.
  • Lee SH, Hungerford JE, Little CD, Iruela-Arispe ML. (1997). Proliferation and differentiation of smooth muscle cell precursors occurs simultaneously during the development of the vessel wall. Dev Dyn 209:342–352.
  • Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. (2000). Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342:626–633.
  • Lee T, Hacohen N, Krasnow M, Montell DJ. (1996). Regulated breathless receptor tyrosine kinase activ-ity required to pattern cell migration and branching in the Drosophila tracheal system. Genes Dev 10: 2912–2921.
  • Lindahl P, Johansson BR, Leveen P, Betsholtz C. (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242–245.
  • Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gib-son ym, Lip GY. (2000). Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: Relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 41:2115–2119.
  • Liston SL. (1984). Nonbacterial inflammation as a means of enhancing skin flap survival. Laryngo-scope 94:1075–1085.
  • Lloyd PG, Yang HT, Terjung RL. (2001). Arterio-genesis and angiogenesis in rat ischemic hindlirnb: Role of nitric oxide. Am J Physiol 281:H2528–H2538.
  • Manabe I, Owens GK. (2001). CArG elements con-trol smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest 107: 823–834.
  • McDougall JJ, Yeung G, Leonard CA, Sutherland C, Bray RC. (2000). Adaptation of post-traumatic an-giogenesis in the rabbit knee by apposition of torn ligament. J Orthop Res 18:663–670.
  • McLeod DS, Taomoto M, Cao J, Zhu Z, Witte L, Lutty GA. (2002). Localization of VEGF receptor-2 (K DR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 43: 474–482.
  • Meneses PI, Hajjar KA, Berns KI, Duvoisin RM. (2001). Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinop-athy model. Gene Ther 8:646–648.
  • Milkiewicz M, Brown MD, Egginton S, Hudlicka O. (2001). Association between shear stress, angiogen-esis, and VEGF in skeletal muscles in vivo. Micro-circulation 8:229–241.
  • Moehler TM, Neben K, Ho AD, Goldschmidt H. (2001). Angiogenesis in hematologic malignancies. Ann Hematol 80:695–705.
  • Moller PH, Ivarsson K, Roos G, Radnell M, Persson B, Tranberg KG, Stenrarn U. (1997). Angiogenesis inhibitor TNP-470 augments the effect of repeated arterial ischemia on growth but does not affect take in a rat liver tumor model. Anticancer Res 17:2401–2406.
  • Monos E, Lorant M, Feher E. (1997). Mechanisms of vascular adaptation to long-term orthostatic gravitational loading. J Gravit Physiol 4:P39–P40.
  • Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. (2002). Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000.
  • Nash GF, Walsh DC, Kakkar AK. (2001). The role of the coagulation system in tumor angiogenesis. Lancet 2:608–613.
  • O'Byrne KJ, Dalgleish AG. (2001). Chronic immune activation and inflammation as the cause of malig-nancy. Br J Cancer 85:473–483.
  • O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285.
  • O'Toole G, MacKenzie D, Buckley MF, Lindeman R, Poole M. (2001). A review of therapeutic angiogen-esis and consideration of its potential applications to plastic and reconstructive surgery. Br J Plast Surg 54:1–7.
  • Parker SB, Dobrian AD, Wade SS, Prewitt RL. (2000). AT (1) receptor inhibition does not reduce arterial wall hypertrophy or PDGF-A expression in renal hypertension. Am J Physiol 278:H613–H622.
  • Patan S, Munn LL, Tanda S, Roberge S, Jain RK, Jones RC. (2001). Vascular morphogenesis and re-modeling in a model of tissue repair: Blood vessel formation and growth in the ovarian pedicle after ovariectomy. Circ Res 89:723–731.
  • Peale FV, Gerritsen ME. (2001). Gene profiling techniques and their application in angiogenesis and vascular development. J Pathol 195:7–19.
  • Preissner KT, Kanse SM, Hammes HP. (1997). In-tegrin chatter and vascular function in diabetic ret-inopathy. Horm Metab Res 29:643–645.
  • Price RJ, Owens GK, Skalak TC. (1994). Irnrnuno-histochemical identification of arteriolar develop-ment using markers of smooth muscle differentia-tion: Evidence that capillary arterialization proceeds from terminal arterioles. Circ Res 75:520–527.
  • Price RJ, Skalak TC. (1996). Chronic alpha-1 ad-renergic blockade stimulates terminal and arcade arteriolar growth in skeletal muscle. Am J Physiol 271:H752–H759.
  • Price RJ, Skalak TC. (1998). Prazosin administra-tion enhances proliferation of arteriolar adventitial fibroblasts. Micro vasc Res 55:138–145.
  • Price RJ, Less JR, Van Gieson EJ, Skalak TC. (2002). Hemodynarnic stresses and structural re-modeling of anastomosing arteriolar networks: De-sign principles of collateral arteries. Microcircula-tion 9:111–124.
  • Pries AR, Secomb TW, Gaehtgens P. (1995). Struc-ture and hemodynarnics of microvascular networks: Heterogeneity and correlations. Am J Physiol 269: H1713–H1722.
  • Pries AR, Secomb TW, Gaehtgens P. (1998). Struc-tural adaptation and stability of microvascular net-works: Theory and simulations. Am J Physiol 275:H349–H360.
  • Quinlan TR, Li D, Laubach VE, Shesely EG, Zhou N, Johns RA. (2000). ENOS-deficient mice show reduced pulmonary vascular proliferation and re-modeling to chronic hypoxia. Am J Physiol 279: L641–L650.
  • Rendell MS, Finegan MF, Pisarri T, Healy JC, Lind A, Milliken BK, Finney DE, Bonner RF. (1999). A comparison of the cutaneous microvascular proper-ties of the spontaneously hypertensive rat and the Wistar-Kyoto rat. Comp Biochem Physiol A Mol In-tegr Physiol A122:399–406.
  • Reynolds JD. (2001). The management of retinop-athy of prematurity. Paediatr Drugs 3:263–272.
  • Rezaee M, Penta K, Quetermous T. (2002). Dell mediates VSMC adhesion, migration, and prolifera-tion through interaction with integrin alpha(v) beta(3). Am J Physiol 282:H1924–H1932.
  • Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA, Wagner PD. (1999). Human VEGF gene expression in skeletal muscle: Effect of acute normoxic and hypoxic exercise. Am J Physiol 277:H2247–H2252.
  • Rieder MJ, Roman RJ, Greene AS. (1997). Reversal of microvascular rarefaction and reduced renal mass hypertension. Hypertension 30:120–127.
  • Rucker M, Roesken F, Schafer T, Spitzer WJ, Voll-mar B, Menger MD. (1999). In vivo analysis of the microcirculation of osteomyocutaneous flaps using fluorescence microscopy. Br J Plast Surg 52:644–652.
  • Scatena M, Giachelli C. (2002). The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway: Potential role in angiogenesis. Trends Cardiovasc Med 12:83–88.
  • Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Fridrich C, Podzuweit T, Schaper W. (2002). Con-tribution of arteriogenesis and angiogenesis to post-occlusive hindlirnb perfusion in mice. J Mol Cell Cardiol 34:775–787.
  • Schubert V. (2000). The influence of local heating on skin microcirculation in pressure ulcers, moni-tored by a combined laser Doppler and transcuta-neous oxygen tension probe. Clin Physiol 20:413–421.
  • Shintani S, Murohara R, Ikeda H, Ueno T, Sasaki K, Duan J, Imaizurni T. (2001). Augmentation of post-natal neovascularization with autologous bone mar-row transplantation. Circulation 103:897–903.
  • Silvestre JS, Levy BI. (2002). Angiogenesis therapy in ischemic disease. Arch Mal Coeur Vaiss 95:189–196.
  • Simons M, Bonow RO, Chronos NA, Cohen DJ, Gior-dano FJ, Hammond HK, Laharn RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK. (2000). Clinical trials in coronary angiogenesis: Issues, problems, consensus. Circulation 102:e73–e86.
  • Skalak TC, Price RJ. (1996). The role of mechanical stresses in microvascular remodeling. Microcircula-tion 3:143–165.
  • Song J, Qi M, Kaul S, Price RJ. (2002). Stimulation of arteriogenesis in skeletal muscle by microbubble destruction with ultrasound. Circulation 106:1550–1555.
  • Stenrnark KR, Bouchey D, Nemenoff R, Dempsey EC, Das M. (2000). Hypoxia-induced pulmonary vascular remodeling: Contribution of the adventitial fibroblasts. Physiol Res 49:503–517.
  • Streit M, Stephen AE, Hawighorst T, Matsuda K, Lange-Asschenfeldt B, Brown LF, Vacanti JP, Det-mar M. (2002). Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. Cancer Res 62: 2004–2012.
  • Stupack DG, Cheresh DA. (2002). ECM remodeling regulates angiogenesis: Endothelial integrins look for new ligands. Sci STKE 119: PE7.
  • Sunderkotter C, Steinbrink K, Goebeler M, Bhard-waj R, Sorg C. (1994). Macrophages and angiogen-esis. J Leukoc Biol 55:410–422.
  • Sun i C, Jones PF, Patan S, Bartunkova S, Maison-pierre PC, Davis S, Sato TN, Yancopoulos GD. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171–1180.
  • Swift ME, Kleinman HK, DiPietro LA. (1999). Im-paired wound repair and delayed angiogenesis in aged mice. Lab Invest 79:1479–1487.
  • Takeshita S, Tomiyama H, Yokoyarna N, Kawa-mura Y, Furukawa T, Ishigai Y, Shibano T, Isshiki T, Sato T. (2001). Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res 52:314–320.
  • Tardy Y, Resnick N, Nagel T, Girnbrone MA, Dewey CF. (1997). Shear stress gradients remodel endothe-lial monolayers in vitro via a cell proliferation- migration-loss cycle. Arterioscler Thromb Vasc Biol 17:3102–3106.
  • Tonnensen MG, Feng X, Clark RF. (2000). Angio-genesis in wound healing. J Invest Dermatol 5:40–46.
  • Tuttle JL, Hahn TL, Sanders BM, Witzmann FA, Miller SJ, Dalsing MC, Unthank JL. (2002). Im-paired collateral development in mature rats. Am J Physiol 283:H146–H155.
  • Tyagi SC. (1997). Vasculogenesis and angiogenesis: Extracellular matrix remodeling in coronary collat-eral arteries and the ischemic heart. J Cell Biochem 65:388–394.
  • Van Royen N, Piek JJ, Buschrnann I, Hoefer I, Voskuil M, Schaper W. (2001). Stimulation of ar-teriogenesis; a new concept for the treatment of ar-terial occlusive disease. Cardiovasc Res 49:543–553.
  • Van Royen N, Piek JJ, Schaper W, Bode C, Busch-mann I. (2001). Arteriogenesis: Mechanisms and modulation of collateral artery development. J Nucl Cardiol 8:687–693.
  • Van Royen N, Hoefer I, Buschrnann I, Heil M, Kos-tin S, Deindl E, Vogel S, Korff T, Augustin H, Bode C, Piek JJ, Schaper W. (2002). Exogenous applica-tion of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASER J 16:432–434.
  • Verma D. (1993). Pathogenesis of diabetic retinop-athy: The missing link? Med Hypotheses 41:205–210.
  • Veves A, King GL. (2001). Can VEGF reverse dia-betic retinopathy in human subjects? J Clin Invest 107:1215–1218.
  • von Dassow G, Meir E, Munro EM, Odell GM. (2000). The segment polarity network is a robust developmental module. Nature 406:188–192.
  • Wagner PD. (2001). Skeletal muscle angiogenesis: A possible role for hypoxia. Adv Exp Med Biol 502:21–38.
  • Walsh DA, Pearson CI. (2001). Angiogenesis in the pathogenesis of inflammatory joint and lung dis-eases. Arthritis Res 3:147–153.
  • Watanabe M, Jafri A, Fisher SA. (2001). Apoptosis is required for the proper formation of the ven-triculo -arterial connections. Dev Biol 240:274–288.
  • Witzenbichler B, Maisonpierre PC, Jones P, Yanco-poulos GD, Isner JM. (1998). Chemotactic proper-ties of angiopoietin-1 and -2, ligands for the endo-thelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273:18514–18521.
  • Wykoff CC, Pugh CW, Harris AL, Maxwell PH, Rat-cliffe PJ. (2001). The HIF pathway: Implications for patterns of gene expression in cancer. Novartis Foundation Symp 240:212–225.
  • Yamaguchi S, Yamaguchi M, Yatsuyanagi E, Yun SS, Nakajirna N, Madri JA, Surnpio BE. (2002). Cy-clic strain stimulates early growth response gene product 1-mediated expression of membrane type 1 matrix metalloproteinase in endothelium. Lab Invest 82:949–956.
  • Yoshirnura S, Masuzaki H, Miura K, Muta K, Gotoh H, Ishirnaru T. (1999). Diagnosis of fetal pulmonary hypoplasia by measurement of blood flow velocity waveforms of pulmonary arteries with Doppler ul-trasonography. Am J Obstet Gynecol 180:441–446.
  • Zeller PJ, Skalak TC, Ponce AM, Price RJ. (2001). In vivo chemotactic properties and spatial expression of PDGF in developing mesenteric microvascular networks. Am J Physiol 280:H2116–H2125.
  • Zhang ZG, Zhang L, Tsang W, Soltanian-Zateh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M. (2002). Correlation of VEGF and angio-poietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ische-mia. J Cereb Blood Flow Metab 22:379–392.
  • Zhang ZG, Zhang L, Jiang Q, Chopp M. (2002). Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 90: 284–288.
  • Zweifach BW. (1983). The microcirculation in ex-perimental hypertension: State-of-the-art review. Hypertension 5:110–116.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.